# A hospital is revising its high-alert medication safety program. For each proposed policy statement, identify whether it is an evidence-based risk control or needs revision.

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=393406&lang=en  
> language: en  
> subject: Medication Administration  
> category: PPT

## Question

A hospital is revising its high-alert medication safety program. For each proposed policy statement, identify whether it is an evidence-based risk control or needs revision.

|  | Evidence-based risk control | Needs revision |
| --- | --- | --- |
| Limit independent double checks to selected greatest-risk high-alert workflows identified by the organization |  |  |
| Have two qualified clinicians verify critical variables independently and compare results afterward |  |  |
| Require an independent double check for every dose solely because a medication is on a high-alert list |  |  |
| Use independent double checks as the only safeguard instead of standardization, barcode scanning, and smart-pump limits |  |  |
| State that every hospital must use one identical Joint Commission or ISMP double-check list |  |  |
| Audit adherence, discrepancies detected, delays, errors, and patient outcomes to evaluate the policy |  |  |

## Explanation

A high-alert designation does not mean every dose or every medication automatically requires an independent double check. ISMP recommends layered system controls and limiting independent double checks to selected high-alert medications or workflows with the greatest organizational risk, such as IV insulin, heparin infusions, opioid infusions, and chemotherapy when designated by local policy. Each clinician performs the check independently, including critical patient, medication, concentration, dose, route, rate, line, and pump variables, then compares results and resolves discrepancies. Independent double checks should complement rather than replace standardization, pharmacy review, barcode scanning, smart-pump limits, and outcome monitoring.

## In-depth explanation

Correct Answer
Use layered safety controls, reserve independent double checks for selected greatest-risk workflows under the organization's policy, perform each check independently, and measure whether the process prevents harm. Revise any policy that requires the same double-check list everywhere or relies on double checks as the only safety layer.

Why It Fits
High-alert medications cause more serious harm when errors occur, but a high-alert label alone does not create a universal double-check mandate for every dose. ISMP recommends selecting the highest-risk workflows within each organization and combining checks with stronger system controls.

Clinical Picture
An independent double check is a final comparison between two separately completed assessments. It is not one clinician reading values aloud while the other agrees, and it cannot repair a poorly designed medication system by itself.

Memory Link
Select the highest risk, check independently, compare afterward, and keep the system safeguards.

NCLEX Rule
Follow the organization's approved medication policy while recognizing the safety principle behind it. Avoid absolute claims that ISMP or The Joint Commission requires one identical independent-double-check list in every hospital.

Why the Alternatives Fail
Applying double checks to every high-alert medication dilutes attention and increases work without targeting the greatest risk. Replacing barcode scanning, standard concentrations, smart-pump limits, or pharmacy review with a double check removes stronger defenses.

Source
1ISMP 2024-2025 Targeted Medication Safety Best Practices for Hospitals

## Clinical scenario

The medication-safety committee is applying ISMP guidance. The organization uses standard concentrations, barcode scanning, smart-pump limits, pharmacy review, and independent double checks for selected highest-risk workflows.

## Key concepts

- **High-alert medication** — Drug with high risk of significant patient harm if used in error; includes insulin, heparin, opioids, chemo, NMBA.
- **Independent double-check (IDC)** — Two qualified clinicians SEPARATELY verify the order, drug, dose, route, patient, line, and pump before administration.
- **ISMP high-alert list** — Institute for Safe Medication Practices list of medications requiring extra safeguards.

## Related questions

- [Before giving a scheduled dose of digoxin, the nurse obtains an apical pulse of 54/min in …](https://mymerci.kr/pages/nclex_q.php?qn_id=374883&lang=en)
- [An older adult taking digoxin reports nausea, poor appetite, and yellow-green halos. The a…](https://mymerci.kr/pages/nclex_q.php?qn_id=374884&lang=en)
- [A client with diabetes who uses insulin and takes propranolol reports sudden sweating and …](https://mymerci.kr/pages/nclex_q.php?qn_id=374893&lang=en)
- [A client with bronchial asthma and current wheezing has a first dose of propranolol prescr…](https://mymerci.kr/pages/nclex_q.php?qn_id=374894&lang=en)
- [Which response by the nurse is most appropriate?](https://mymerci.kr/pages/nclex_q.php?qn_id=374901&lang=en)
- [Before administering spironolactone, the nurse notes a potassium level of 5.8 mEq/L and ne…](https://mymerci.kr/pages/nclex_q.php?qn_id=374902&lang=en)
- [A client taking lisinopril develops sudden swelling of the lips and tongue with hoarseness…](https://mymerci.kr/pages/nclex_q.php?qn_id=374903&lang=en)
- [A client taking losartan for hypertension reports a positive home pregnancy test. Which in…](https://mymerci.kr/pages/nclex_q.php?qn_id=374904&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=393406&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=393406&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=393406&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=393406&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=393406&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._